Psylo
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11-31 York St L 2, Sydney, New South Wal...Website
psylo.bioRevenue
$7.4 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Psylo
Psylo develop next-generation therapeutics inspired by psychedelics from nature. Using computational chemistry the company is optimizing the pharmacology of next-generation compounds to produce medicines which are applicable to a broader patient population.Explore more
Psylo Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Psylo your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Psylo launches new products
Earning: See what the market has to say on Psylo recently announced quarterly report
Funding: Get notified immidiatlly once Psylo has new funding data
Check out if Psylo is spiking on competitors!
Click to see if Psylo had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Psylo, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Psylo has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Psylo
Recommended Actions
Find VP level buyers at Psylo
Find 2 more new buyers
Compare Similar Companies to Psylo
Compare insights from companies similar to Psylo, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Psylo is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Psylo is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Psylo.
Psylo financials insights
Gather financial insights about Psylo, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$5M
2024
Angel/Seed
$13M
Psylo Tech Stack
A closer look at the technologies used by Psylo
Most Recent Scoops
Open Position
Funding
Funding
Open Position
Funding
Psylo News & Media
$3M GRANT TO ACCELERATE DEVELOPMENT OF NEUROPLASTOGENS FOR SUBSTANCE USE DISORDER TREATMENT
CRC-P GRANT SECURED BY TESSARA THERAPEUTICS, PSYLO, AND THE UNIVERSITY OF SYDNEY TO ADVANCE BRAIN-REWIRING TREATMENTS FOR ADDICTION BOULDER, Colo., Oct. 29, 2024 /PRNewswire/ -- Tessara Therapeutics, Psylo, and the University of Sydney are pleased to announce their receipt of a $3 million Cooperative Research Centres Projects (CRC-P) grant. Matching funds committed by the partners increases the total project investment to $6.2 million. The collaboration will focus on the development of neuroplasPsylo's US trip: why the psychedelics startup is keeping one foot in Australia as it expands stateside
After a US$8 million seed round, Sydney startup Psylo is shipping its headquarters to the US. But there’s a reason why American co-founder and CEO Joshua Ismin is staying put.Superseeder: psychedelic biotech Psylo plants $12 million in latest 'Seed' round
It's Psylo's second major Seed round, having previously banked a A$5 million Seed raise in late 2022 and $1.1m in 2021.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Psylo
Sign Up For FreeTo access detailed company insights
Psylo develop next-generation therapeutics inspired by psychedelics from nature. Using computational chemistry the company is optimizing the pharmacology of next-generation compounds to produce medicines which are applicable to a broader patient population.... Read More
